Perennial allergic rhinitis
MONDO:0024332Allergic rhinitis caused by indoor allergens and lasting year round.
Also known as: non-seasonal allergic rhinitis, nonseasonal allergic rhinitis, perennial allergic rhinitis
56 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Massive asthma study tests phone apps and simple home fixes
Disease control Not yet recruitingThis large study aims to create a digital screening and management system for adults with asthma and allergies. Nearly 10,000 participants will use a smartphone platform to track symptoms and receive guidance on three non-drug strategies: avoiding allergens (like dust mites), inc…
Phase: NA • Sponsor: Beijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New dissolving film could tame dust mite allergies without shots
Disease control Not yet recruitingThis study tests a daily dissolving film placed under the tongue to treat dust mite allergic rhinitis (hay fever). About 250 adults in China will use either the active film or a placebo for one year. The goal is to see if the film reduces sneezing, stuffiness, and the need for re…
Phase: PHASE2 • Sponsor: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New allergy shot for teens enters early safety testing
Symptom relief Not yet recruitingThis early-stage study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergies like hay fever, asthma, or food allergies. The main goal is to see if the drug is safe and how the body processes it. Participants will be closely monitored for side effects and …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Cartoons and stories soothe Kids' fear during breathing treatments
Symptom relief Not yet recruitingThis study looks at whether watching cartoons or listening to breath-synchronized interactive stories can help children aged 6-9 feel less afraid and more comfortable while using a nebulizer for breathing medication. About 96 children with respiratory conditions will be randomly …
Phase: NA • Sponsor: Mersin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New shot could quiet constant sniffles for months
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for people with year-round allergies (perennial allergic rhinitis). The goal is to see if it can reduce symptoms like runny nose, congestion, and sneezing better than a placebo. About 135 adults who already use nasal sprays will receiv…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Cold therapy could take the ouch out of blood tests
Symptom relief Not yet recruitingThis study tests if applying cold (cryotherapy) to the wrist before a blood draw from the artery can reduce pain. It involves 258 adults with chronic respiratory diseases who need this test. The goal is to find a simple, drug-free way to make the procedure less painful.
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can a natural spray beat dust mite allergies? new study aims to find out
Symptom relief Not yet recruitingThis study tests whether a natural nasal spray (Puressentiel Allergy Protection) can reduce symptoms of dust mite allergies. Twenty adults with dust mite allergic rhinitis will receive either the spray or a saline placebo before a nasal allergen challenge. Researchers will measur…
Phase: NA • Sponsor: Puressentiel • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
30,000 blood samples could revolutionize rapid disease testing
Knowledge-focused Not yet recruitingThis study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…
Sponsor: LumiraDx UK Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New asthma drug formulation put to the test in healthy adults
Knowledge-focused Not yet recruitingThis study compares two oral formulations of pranlukast, a drug used for asthma and allergic rhinitis, to see if they are equivalent. Sixty healthy adults will receive a single dose of each version in random order under fasting conditions. The main goal is to measure drug levels …
Phase: PHASE1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC